Supplementary Data 2 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer

Jonathan R. Branch,Tammy L. Bush,Vineet Pande,Peter J. Connolly,Zhuming Zhang,Ian Hickson,Janine Ondrus,Steffen Jaensch,James R. Bischoff,Georges Habineza,Geert Van Hecke,Lieven Meerpoel,Kathryn Packman,Christopher J. Parrett,Yolanda Chong,Marco M. Gottardis,Gilles Bignan
DOI: https://doi.org/10.1158/1535-7163.22522980
2023-01-01
Abstract:Enzalutamide activates AR signaling in the absence of androgen in HepG2 transiently transfected with AR F877L and AR F877L/T878A constructs but not AR T878A only
What problem does this paper attempt to address?